Pacific Biosciences of California, Inc. Stock
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 1.620 USD | +2.53% |
|
+18.25% | -13.37% |
| Market Cap | 504M 442M 417M 380M 712M 48.26B 717M 4.99B 1.93B 24.66B 1.89B 1.85B 79.24B | P/E 2026 * |
-3.68x | P/E 2027 * | -3.49x |
|---|---|---|---|---|---|
| Enterprise Value | 972M 853M 806M 734M 1.37B 93.18B 1.38B 9.64B 3.73B 47.61B 3.65B 3.57B 153B | EV / Sales 2026 * |
6.12x | EV / Sales 2027 * | 5.58x |
| Free-Float |
91.09% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PACB | Delayed | |
CBOE
| PACB | Real-time | |
|
Tradegate
| P09 | Real-time | |
|
Boerse Muenchen
| P09 | Real-time | |
|
Deutsche Boerse AG
| P09 | Delayed | |
|
Börse Stuttgart
| P09 | Delayed |
Last Transcript: Pacific Biosciences of California, Inc.
| 1 day | +2.53% | ||
| 1 week | +18.25% | ||
| Current month | +19.56% | ||
| 1 month | +4.52% | ||
| 3 months | -1.82% | ||
| 6 months | +28.57% | ||
| Current year | -13.37% |
| 1 week | 1.36 |  | 1.63 |
| 1 month | 1.25 | | 1.63 |
| Current year | 1.07 | | 2.73 |
| 1 year | 1.07 | | 2.73 |
| 3 years | 0.85 | | 10.65 |
| 5 years | 0.85 | | 31.1 |
| 10 years | 0.85 | | 53.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark van Oene
CEO | Chief Executive Officer | 53 | 2026-08-04 |
Jim Gibson
DFI | Director of Finance/CFO | 57 | 2025-03-30 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 2012-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 2003-12-31 |
Randy Livingston
BRD | Director/Board Member | 72 | 2008-12-31 |
Marshall Mohr
BRD | Director/Board Member | 69 | 2012-01-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/17/26 | Sell | Chief Executive Officer | -26,911 | 0.0087% | ||
| 8/10/26 | Free | Chief Executive Officer | 2,457,018 | 0.7911% | ||
| 6/3/26 | Free | Chairman | 223,492 | 0.0720% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.53% | +18.25% | +33.88% | -80.62% | 504M | |
| -0.50% | +3.62% | +45.40% | +35.46% | 250B | |
| +0.32% | +5.99% | +21.45% | -9.27% | 158B | |
| +1.42% | +3.01% | -8.15% | +39.03% | 143B | |
| -1.70% | +1.34% | -55.27% | -15.70% | 63.65B | |
| +0.65% | -2.23% | +13.17% | +23.08% | 49.74B | |
| -0.03% | +10.43% | +40.04% | +56.37% | 48.71B | |
| +3.29% | +2.95% | -14.28% | -19.03% | 47.94B | |
| +0.75% | +2.82% | +48.62% | +59.19% | 42.59B | |
| -1.42% | +12.68% | +194.47% | +102.55% | 40.77B | |
| Average | +0.36% | +5.60% | +31.93% | +19.11% | 84.44B | |
| Weighted average by Cap. | -0.07% | +4.04% | +26.02% | +25.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 159M 139M 132M 120M 225M 15.23B 226M 1.58B 610M 7.78B 597M 584M 25.01B | 184M 162M 153M 139M 261M 17.67B 262M 1.83B 708M 9.03B 692M 677M 29.01B |
| Net income | -141M -123M -117M -106M -199M -13.48B -200M -1.39B -540M -6.88B -528M -516M -22.13B | -143M -126M -119M -108M -202M -13.71B -204M -1.42B -550M -7.01B -537M -526M -22.52B |
| Net Debt | 469M 411M 388M 354M 663M 44.92B 667M 4.65B 1.8B 22.95B 1.76B 1.72B 73.76B | 525M 460M 435M 396M 742M 50.27B 747M 5.2B 2.01B 25.68B 1.97B 1.93B 82.55B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-25 | US$1.620 | +2.53% | 11,367,889 |
| 26-09-24 | US$1.580 | +12.06% | 11,100,917 |
| 26-09-23 | US$1.410 | -4.08% | 5,257,416 |
| 26-09-22 | US$1.470 | +8.09% | 7,848,551 |
| 26-09-21 | US$1.360 | -0.73% | 6,127,040 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PACB Stock
Select your edition
All financial news and data tailored to specific country editions
